Brinker Capital Investments’s Pharming Group PHAR Stock Holding History

Brinker Capital Investments’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,715	Closed	-$134K	–	1729
2023 Q3	$134K	Buy	+11,715	New	+$146K	﹤0.01%	1575

Other funds holding PHAR

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brinker Capital Investments's PHAR Position: Q4 2023 in Review

Brinker Capital Investments sold out of Pharming Group (PHAR) in Q4 2023, closing a stake of 11,715 shares — an estimated $134K sold.

Brinker Capital Investments first reported a position in PHAR in Q3 2023 and held it in 1 quarter. The position peaked at $134K in Q3 2023. 2 funds tracked by Wall St. Rank hold PHAR as of Q4 2023.

Brinker Capital Investments reported no remaining Pharming Group position as of Q4 2023 after selling out during the quarter.
Brinker Capital Investments sold 11,715 Pharming Group shares in Q4 2023, an estimated $134K.
Brinker Capital Investments first reported a position in Pharming Group in Q3 2023 and held it in 1 quarter.
Brinker Capital Investments's Pharming Group position peaked at $134K in Q3 2023.
2 funds tracked by Wall St. Rank held Pharming Group as of Q4 2023.

Based on Brinker Capital Investments's 13F filing for Q4 2023, filed 31 Jul 2025.